Dirk Kienle

miR-34a as part of the resistance network in chronic lymphocytic leukemia

Thorsten Zenz, Julia Mohr, Eric Eldering et al. · Blood · 2008 · 277 citations · Full text

Medicine, Molecular Biology, Oncology +14

Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival

Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger et al. · Haematologica · 2007 · 216 citations · Full text

Life Sciences, Genetics, Oncology +17

Additional Genetic High-Risk Features Such As 11q Deletion, 17p Deletion, and <i>V3-21</i> Usage Characterize Discordance of ZAP-70 and <i>VH</i> Mutation Status in Chronic Lymphocytic Leukemia

Alexander Kröber, Johannes Bloehdorn, Sebastian Häfner et al. · Journal of Clinical Oncology · 2006 · 193 citations · Full text

Medicine, Hematology, Oncology +15

High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia

Daniel Heintel, Dirk Kienle, Medhat Shehata et al. · Leukemia · 2005 · 158 citations

Life Sciences, Biochemistry, Hematology +13

VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome

Dirk Kienle, Alexander Kröber, Tiemo Katzenberger et al. · Blood · 2003 · 154 citations · Full text

Medicine, Molecular Genetics, Oncology +17